1,321 results on '"Orvieto, Raoul"'
Search Results
2. Determining the optimal daily gonadotropin dose to maximize the oocyte yield in elective egg freezing cycles
3. What is the maximal timeframe between sperm acquisition to sperm cryopreservation, in different “culture” conditions?
4. Triggering final oocyte maturation. The role of human chorionic gonadotropin, gonadotropin-releasing hormone agonist, and dual trigger
5. Human granulosa cells of poor ovarian responder patients display telomeres shortening
6. Outcomes of IVF treatments in women with antiphospholipid antibodies or antiphospholipid syndrome
7. Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
8. Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
9. The effects of Covid-19 mRNA vaccine on adolescence gynecological well-being
10. A review of the 2021/2022 PGDIS Position Statement on the transfer of mosaic embryos
11. Embryos derived from single pronucleus are suitable for preimplantation genetic testing
12. Self-Monitoring of Urinary Hormones in Combination with Telemedicine — a Timely Review and Opinion Piece in Medically Assisted Reproduction
13. Fertility preservation for women with ovarian endometriosis: results from a retrospective cohort study
14. Challenges encountered in predicting live birth after in vitro fertilization in the different phenotypes of patients with polycystic ovary syndrome
15. A validated predictive model for adnexal torsion pre-operative diagnosis
16. The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
17. Pretreatment: Does it improve quantity or quality?
18. Revisiting selected ethical aspects of current clinical in vitro fertilization (IVF) practice
19. The Influence of Cesarean Delivery on Ovarian Reserve: a Prospective Cohort Study
20. Cleavage-stage human embryo arrest, is it embryo genetic composition or others?
21. Predicting IVF outcome in poor ovarian responders
22. The in-vitro effect of gonadotropins’ type and combination on Granulosa cells gene expressions
23. Elective egg freezing patients may benefit from increasing the maximal daily gonadotropin dose above 300IU
24. Exposome Profiling of Environmental Pollutants in Seminal Plasma and Novel Associations with Semen Parameters.
25. “Add-Ons” for Assisted Reproductive Technology: Do Patients Get Honest Information from Fertility Clinics’ Websites?
26. Cleavage vs blastocyst stage embryos: how are they interrelating?
27. Outcomes of Ivf Treatments in Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome
28. Triggering Final Follicular Maturation for IVF Cycles
29. The uncertain science of preimplantation and prenatal genetic testing
30. Does gonadotropin-releasing hormone agonist cause luteolysis by inducing apoptosis of the human granulosa-luteal cells?
31. Is There Any Association Between the Number of Oocytes Retrieved, Women Age, and Embryo Development?
32. What to advise to patients with only one good quality blastocyst, PGT-A or not? Outcomes of 2064 cycles
33. A Natural Cycle Is the Best Protocol for Frozen Embryo Replacement
34. Can Oocyte Diameter Predict Embryo Quality?
35. The role of ICSI vs. conventional IVF for patients with advanced maternal age—a randomized controlled trial
36. Does the time interval between the diagnosis to hysteroscopic evacuation of retained products of conception affect reproductive outcome?
37. Timing day-3 vitrification for PGT-M embryos: pre- or post-blastomere biopsy?
38. Machine learning vs. classic statistics for the prediction of IVF outcomes
39. Can expelled cells/debris from a developing embryo be used for PGT?
40. Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
41. Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?
42. Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers
43. Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials
44. Hormonal Ovarian Treatment
45. Luteal Support
46. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal
47. Controlled Ovarian Stimulation for In Vitro Fertilisation Cycles
48. The effect of body mass index (BMI) and gestational weight gain on adverse obstetrical outcomes in pregnancies following assisted reproductive technology as compared to spontaneously conceived pregnancies
49. Outcomes of singleton versus twin pregnancies in the fifth and sixth decades
50. The expected cumulative incidence of live birth for patients starting IVF treatment at age 41 years or older
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.